MetaADEDB 2.0 @ LMMD
Vortioxetine hydrobromide
(VNGRUFUIHGGOOM-UHFFFAOYSA-N)
Structure
SMILES
Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1.Br
Molecular Formula:
C18H23BrN2S
Molecular Weight:
379.358
Log P:
5.2161
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
40.57
CAS Number(s):
960203-27-4
Synonym(s)
1.
Vortioxetine hydrobromide
2.
1-[2-(2,4-Dimethylphenyl)sulfanylphenyl]piperazin-4-ium;bromide
External Link(s)
PubChem Compound56843850
139064591
ChEBI76015
CHEMBLCHEMBL2107387
KEGGdr:D10185
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 527
Canada Vigilance: 14
Canada Vigilance
US FAERS
2FatigueFAERS: 368
Canada Vigilance: 1
Canada Vigilance
US FAERS
3AstheniaFAERS: 353US FAERS
4AnxietyFAERS: 331
Canada Vigilance: 2
Canada Vigilance
US FAERS
5Feeling abnormalFAERS: 272
Canada Vigilance: 3
Canada Vigilance
US FAERS
6ApathyFAERS: 252
Canada Vigilance: 1
Canada Vigilance
US FAERS
7AngerFAERS: 244US FAERS
8HeadacheFAERS: 242
Canada Vigilance: 3
Canada Vigilance
US FAERS
9HypersomniaFAERS: 195US FAERS
10Mood swingsFAERS: 185US FAERS
11VomitingFAERS: 173
Canada Vigilance: 5
Canada Vigilance
US FAERS
12HyperphagiaFAERS: 163US FAERS
13DizzinessFAERS: 145
Canada Vigilance: 2
Canada Vigilance
US FAERS
14PruritusFAERS: 129
Canada Vigilance: 3
Canada Vigilance
US FAERS
15ConstipationFAERS: 113
Canada Vigilance: 1
Canada Vigilance
US FAERS
16No adverse eventFAERS: 110US FAERS
17Drug ineffectiveFAERS: 92
Canada Vigilance: 27
Canada Vigilance
US FAERS
18Wrong technique in product usage processFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
19AgitationFAERS: 53
Canada Vigilance: 4
Canada Vigilance
US FAERS
20Weight decreasedFAERS: 42US FAERS
21AlopeciaFAERS: 34US FAERS
22TremorFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Adverse eventFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
24OverdoseFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
25UrticariaFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Drug prescribing errorFAERS: 26US FAERS
27PalpitationsFAERS: 26US FAERS
28SomnolenceFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
29MalaiseFAERS: 24
Canada Vigilance: 3
Canada Vigilance
US FAERS
30Completed SuicideFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
31Sexual DysfunctionFAERS: 22US FAERS
32Abdominal discomfortFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
33ArthralgiaFAERS: 20US FAERS
34Personality ChangeFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
35FlatulenceFAERS: 19US FAERS
36HypersensitivityFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
37Eye painFAERS: 16US FAERS
38CryingFAERS: 15US FAERS
39Abdominal PainFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
40BruxismFAERS: 14US FAERS
41Drug administered to patient of inappropriate ageFAERS: 14US FAERS
42MyalgiaFAERS: 13US FAERS
43Serotonin SyndromeFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
44Suicide attemptFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
45Depressed moodFAERS: 11US FAERS
46Inappropriate schedule of drug administrationFAERS: 11US FAERS
47Visual ImpairmentFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
48DysgeusiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
49HypomaniaFAERS: 10US FAERS
50PregnancyFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
51TinnitusFAERS: 10US FAERS
52AmnesiaFAERS: 9US FAERS
53Back PainFAERS: 9US FAERS
54Chest PainFAERS: 9US FAERS
55Emotional disorderFAERS: 9US FAERS
56Erectile dysfunctionFAERS: 9US FAERS
57Feeling jitteryFAERS: 9US FAERS
58Musculoskeletal stiffnessFAERS: 9US FAERS
59NervousnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
60PainFAERS: 9US FAERS
61Peripheral swellingFAERS: 9US FAERS
62Prescribed overdoseFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
63Memory impairmentFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
64TachycardiaFAERS: 8US FAERS
65AkathisiaFAERS: 7US FAERS
66Blood sodium decreasedFAERS: 7US FAERS
67HungerFAERS: 7US FAERS
68HypophagiaFAERS: 7US FAERS
69Mental impairmentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
70ParanoiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Restless Legs SyndromeFAERS: 7US FAERS
72TachyphreniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
73AnorgasmiaFAERS: 6US FAERS
74Drug dose omissionFAERS: 6US FAERS
75EpistaxisFAERS: 6US FAERS
76FlushingFAERS: 6US FAERS
77Poor quality sleepFAERS: 6US FAERS
78Atrial FibrillationFAERS: 5US FAERS
79Bipolar DisorderFAERS: 5US FAERS
80ChillsFAERS: 5US FAERS
81DehydrationFAERS: 5US FAERS
82LethargyFAERS: 5US FAERS
83Muscle tightnessFAERS: 5US FAERS
84Night sweatsFAERS: 5US FAERS
85RetchingFAERS: 5US FAERS
86Unevaluable eventFAERS: 5US FAERS
87VertigoFAERS: 5US FAERS
88Alcohol interactionFAERS: 4US FAERS
89Burning sensationFAERS: 4US FAERS
90Cerebrovascular accidentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
91Chest discomfortFAERS: 4US FAERS
92DiplopiaFAERS: 4US FAERS
93Drug screen positiveFAERS: 4US FAERS
94DyspepsiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Incorrect dose administeredFAERS: 4US FAERS
96Irritable Bowel SyndromeFAERS: 4US FAERS
97Joint stiffnessFAERS: 4US FAERS
98Joint swellingFAERS: 4US FAERS
99MenorrhagiaFAERS: 4US FAERS
100Oropharyngeal painFAERS: 4US FAERS
101Product use issueFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
102SchizophreniaFAERS: 4US FAERS
103SwellingFAERS: 4US FAERS
104Therapy cessationFAERS: 4US FAERS
105Urinary IncontinenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
106Accidental overdoseFAERS: 3US FAERS
107AcneFAERS: 3US FAERS
108AngioedemaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
109BlepharospasmFAERS: 3US FAERS
110DisorientationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Drug screen false positiveFAERS: 3US FAERS
112EructationFAERS: 3US FAERS
113Gastric BypassFAERS: 3US FAERS
114Gastrointestinal PainFAERS: 3US FAERS
115Impaired gastric emptyingFAERS: 3US FAERS
116Impaired work abilityFAERS: 3US FAERS
117InfluenzaFAERS: 3US FAERS
118MetrorrhagiaFAERS: 3US FAERS
119Middle insomniaFAERS: 3US FAERS
120Panic DisorderFAERS: 3US FAERS
121Product dispensing errorFAERS: 3US FAERS
122Product dose omissionFAERS: 3US FAERS
123Pulmonary EmbolismFAERS: 3US FAERS
124StressFAERS: 3US FAERS
125Vitreous floatersFAERS: 3US FAERS
126YawningFAERS: 3US FAERS
127Accidental exposure to product by childFAERS: 2US FAERS
128Acute myocardial infarctionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
129AtaxiaFAERS: 2US FAERS
130AversionFAERS: 2US FAERS
131Blood glucose increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Blood urine presentFAERS: 2US FAERS
133BradyphreniaFAERS: 2US FAERS
134Breast tendernessFAERS: 2US FAERS
135Cardiac FlutterFAERS: 2US FAERS
136CataractFAERS: 2US FAERS
137Choking sensationFAERS: 2US FAERS
138Drug dispensed to wrong patientFAERS: 2US FAERS
139Drug ineffective for unapproved indicationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
140Dry skinFAERS: 2US FAERS
141DysarthriaFAERS: 2US FAERS
142DysuriaFAERS: 2US FAERS
143EpilepsyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Eye irritationFAERS: 2US FAERS
145Facial paralysisFAERS: 2US FAERS
146Feeling ColdFAERS: 2US FAERS
147Flat affectFAERS: 2US FAERS
148Hallucinations, mixedFAERS: 2US FAERS
149HyperacusisFAERS: 2US FAERS
150Impaired driving abilityFAERS: 2US FAERS
151Inappropriate schedule of product administrationFAERS: 2US FAERS
152IncontinenceFAERS: 2US FAERS
153Increased tendency to bruiseFAERS: 2US FAERS
154Intraocular pressure test abnormalFAERS: 2US FAERS
155LaryngospasmFAERS: 2US FAERS
156Mouth swellingFAERS: 2US FAERS
157Musculoskeletal PainFAERS: 2US FAERS
158MydriasisFAERS: 2US FAERS
159NasopharyngitisFAERS: 2US FAERS
160Negative thoughtsFAERS: 2US FAERS
161Obsessive-Compulsive DisorderFAERS: 2US FAERS
162PancreatitisFAERS: 2US FAERS
163Pelvic PainFAERS: 2US FAERS
164PhotophobiaFAERS: 2US FAERS
165Prescribed underdoseFAERS: 2US FAERS
166Product use in unapproved indicationFAERS: 2
Canada Vigilance: 6
Canada Vigilance
US FAERS
167Rash erythematousFAERS: 2US FAERS
168RestlessnessFAERS: 2US FAERS
169SepsisFAERS: 2US FAERS
170Sleep ParalysisFAERS: 2US FAERS
171Slow speechFAERS: 2US FAERS
172StomatitisFAERS: 2US FAERS
173Supraventricular tachycardiaFAERS: 2US FAERS
174SyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Tardive DyskinesiaFAERS: 2US FAERS
176ThirstFAERS: 2US FAERS
177Transcription medication errorFAERS: 2US FAERS
178Urinary RetentionFAERS: 2US FAERS
179Violence-related symptomFAERS: 2US FAERS
180AbasiaFAERS: 1US FAERS
181Abnormal sleep-related eventFAERS: 1US FAERS
182Abnormal weight gainFAERS: 1US FAERS
183AcidosisFAERS: 1US FAERS
184Activation syndromeFAERS: 1US FAERS
185Activities of daily living impairedFAERS: 1US FAERS
186Adnexa uteri painFAERS: 1US FAERS
187AgeusiaFAERS: 1US FAERS
188Alcohol abuseFAERS: 1US FAERS
189Alopecia AreataFAERS: 1US FAERS
190Ammonia abnormalFAERS: 1US FAERS
191Anaphylactic shockFAERS: 1US FAERS
192Angina PectorisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
193Angle Closure GlaucomaFAERS: 1US FAERS
194AnhedoniaFAERS: 1US FAERS
195Anorectal swellingFAERS: 1US FAERS
196Anticonvulsant drug level increasedFAERS: 1US FAERS
197Apparent deathFAERS: 1US FAERS
198ArthritisFAERS: 1US FAERS
199AsthenopiaFAERS: 1US FAERS
200AutoscopyFAERS: 1US FAERS
201BalanoposthitisFAERS: 1US FAERS
202Benzodiazepine drug levelFAERS: 1US FAERS
203Blood glucose decreasedFAERS: 1US FAERS
204Blood potassium decreasedFAERS: 1US FAERS
205Blood prolactin increasedFAERS: 1US FAERS
206BradycardiaFAERS: 1US FAERS
207CatatoniaFAERS: 1US FAERS
208CellulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Central nervous system lesionFAERS: 1US FAERS
210ChokingFAERS: 1US FAERS
211CholestasisFAERS: 1US FAERS
212ColitisFAERS: 1US FAERS
213Compulsive cheek bitingFAERS: 1US FAERS
214Congenital neurological disorderFAERS: 1US FAERS
215Contraindicated product administeredFAERS: 1US FAERS
216Coronary Artery DiseaseFAERS: 1US FAERS
217DeliriumFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
218Depressed Level of ConsciousnessFAERS: 1US FAERS
219DiplegiaFAERS: 1US FAERS
220DiscomfortFAERS: 1US FAERS
221DissociationFAERS: 1US FAERS
222Drug effect incompleteFAERS: 1US FAERS
223Drug withdrawal syndromeFAERS: 1US FAERS
224DuodenitisFAERS: 1US FAERS
225DysmorphismFAERS: 1US FAERS
226DysphoniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
227EcchymosisFAERS: 1US FAERS
228Electrocardiogram QT interval abnormalFAERS: 1US FAERS
229Embolic strokeFAERS: 1US FAERS
230EnuresisFAERS: 1US FAERS
231ErythemaFAERS: 1US FAERS
232Exfoliative rashFAERS: 1US FAERS
233Exposure during breast feedingFAERS: 1US FAERS
234Exposure via breast milkFAERS: 1US FAERS
235Extra dose administeredFAERS: 1US FAERS
236Female Orgasmic DisorderFAERS: 1US FAERS
237FibromyalgiaFAERS: 1US FAERS
238Food cravingFAERS: 1US FAERS
239Foreign body in respiratory tractFAERS: 1US FAERS
240FormicationFAERS: 1US FAERS
241Frustration tolerance decreasedFAERS: 1US FAERS
242GastritisFAERS: 1US FAERS
243GastroenteritisFAERS: 1US FAERS
244Gastrointestinal infectionFAERS: 1US FAERS
245Gastrointestinal inflammationFAERS: 1US FAERS
246Gastrointestinal motility disorderFAERS: 1US FAERS
247GlaucomaFAERS: 1US FAERS
248Gluten sensitivityFAERS: 1US FAERS
249Head discomfortFAERS: 1US FAERS
250Histamine level increasedFAERS: 1US FAERS
251HomicideFAERS: 1US FAERS
252HordeolumFAERS: 1US FAERS
253HostilityFAERS: 1US FAERS
254HyperchlorhydriaFAERS: 1US FAERS
255HyperkeratosisFAERS: 1US FAERS
256Hypertensive emergencyFAERS: 1US FAERS
257HyperventilationFAERS: 1US FAERS
258HypokinesiaFAERS: 1US FAERS
259HypotensionFAERS: 1US FAERS
260HypothyroidismFAERS: 1US FAERS
261Impaired self-careFAERS: 1US FAERS
262Inappropriate affectFAERS: 1US FAERS
263IncoherentFAERS: 1US FAERS
264InfectionFAERS: 1US FAERS
265Infectious colitisFAERS: 1US FAERS
266InflammationFAERS: 1US FAERS
267Initial insomniaFAERS: 1US FAERS
268Intentional product use issueFAERS: 1US FAERS
269Intentional self-injuryFAERS: 1US FAERS
270Intercepted drug prescribing errorFAERS: 1US FAERS
271Intercepted product prescribing errorFAERS: 1US FAERS
272Intestinal villi atrophyFAERS: 1US FAERS
273Libido disorderFAERS: 1US FAERS
274Limb discomfortFAERS: 1US FAERS
275Lip pruritusFAERS: 1US FAERS
276LymphadenopathyFAERS: 1US FAERS
277Macular degenerationFAERS: 1US FAERS
278Medication residue presentFAERS: 1US FAERS
279MetamorphopsiaFAERS: 1US FAERS
280Motion SicknessFAERS: 1US FAERS
281Multiple allergiesFAERS: 1US FAERS
282Myocardial InfarctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
283MyocarditisFAERS: 1US FAERS
284MyopiaFAERS: 1US FAERS
285NarcolepsyFAERS: 1US FAERS
286Neck PainFAERS: 1US FAERS
287NeuralgiaFAERS: 1US FAERS
288NoduleFAERS: 1US FAERS
289Obsessive thoughtsFAERS: 1US FAERS
290Ocular discomfortFAERS: 1US FAERS
291Oculogyric crisisFAERS: 1US FAERS
292Oral candidiasisFAERS: 1US FAERS
293Oral pruritusFAERS: 1US FAERS
294PancytopeniaFAERS: 1US FAERS
295ParaplegiaFAERS: 1US FAERS
296ParasomniaFAERS: 1US FAERS
297Pelvic discomfortFAERS: 1US FAERS
298PeriodontitisFAERS: 1US FAERS
299PetechiaeFAERS: 1US FAERS
300Physical assaultFAERS: 1US FAERS
301PneumoniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
302PolydipsiaFAERS: 1US FAERS
303PolymyositisFAERS: 1US FAERS
304PresyncopeFAERS: 1US FAERS
305Primary amyloidosisFAERS: 1US FAERS
306Product complaintFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Product measured potency issueFAERS: 1US FAERS
308Product name confusionFAERS: 1US FAERS
309Product selection errorFAERS: 1US FAERS
310ProteinuriaFAERS: 1US FAERS
311PsoriasisFAERS: 1US FAERS
312Rebound effectFAERS: 1US FAERS
313Reflux gastritisFAERS: 1US FAERS
314Renal painFAERS: 1US FAERS
315Respiratory distressFAERS: 1US FAERS
316Salt cravingFAERS: 1US FAERS
317Secretion dischargeFAERS: 1US FAERS
318Seizure like phenomenaFAERS: 1US FAERS
319Sensitive skinFAERS: 1US FAERS
320Sinus bradycardiaFAERS: 1US FAERS
321SinusitisFAERS: 1US FAERS
322Skin discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
323Skin lacerationFAERS: 1US FAERS
324Sleep-related eating disorderFAERS: 1US FAERS
325SomnambulismFAERS: 1US FAERS
326Stevens-Johnson SyndromeFAERS: 1US FAERS
327Stool analysis abnormalFAERS: 1US FAERS
328Sudden deathFAERS: 1US FAERS
329SunburnFAERS: 1US FAERS
330Swelling of eyelidFAERS: 1US FAERS
331Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
332TachyphylaxisFAERS: 1US FAERS
333Temperature regulation disorderFAERS: 1US FAERS
334Tension HeadacheFAERS: 1US FAERS
335Therapeutic response delayedFAERS: 1US FAERS
336Therapeutic response unexpectedFAERS: 1US FAERS
337Therapy changeFAERS: 1US FAERS
338Therapy non-responderFAERS: 1US FAERS
339Therapy partial responderFAERS: 1US FAERS
340Throat irritationFAERS: 1US FAERS
341ThrombosisFAERS: 1US FAERS
342Thrombotic strokeFAERS: 1US FAERS
343Toxicity to various agentsFAERS: 1US FAERS
344UlcerFAERS: 1US FAERS
345Urge IncontinenceFAERS: 1US FAERS
346UveitisFAERS: 1US FAERS
347Vitreous DetachmentFAERS: 1US FAERS
348jaundiceFAERS: 1US FAERS
349treatment failureFAERS: 1US FAERS
350Pancreatic carcinomaCanada Vigilance: 1Canada Vigilance
351Psychiatric symptomCanada Vigilance: 1Canada Vigilance
352Respiratory FailureCanada Vigilance: 1Canada Vigilance
353Therapeutic product effect decreasedCanada Vigilance: 5Canada Vigilance
354Therapeutic product ineffectiveCanada Vigilance: 3Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.